CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. IBM
9. PRIM
10. PFE

Go back to CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
(NASDAQ: CRVO) Delayed: 3.78 -0.35 (8.47%)
Previous Close $4.13    52 Week High $ 
Open $3.97    52 Week Low $ 
Day High $4.11    P/E N/A 
Day Low $3.70    EPS $ 
Volume 1,299,921